Scientists Nearing Breakthrough on Life-Saving Antibody Treatment for Coronavirus
By HospiMedica International staff writers Posted on 08 Jun 2020 |
Illustration
AstraZeneca (Cambridgeshire, England) is close to achieving a breakthrough on life-saving COVID-19 antibody treatment for the elderly and vulnerable population.
Scientists at AstraZeneca are developing a cloned antibody injection that instantly arms the human body to neutralize the coronavirus. This could prove to be a game-changer for COVID-19 patients in the first stages of coronavirus. According to The Sunday Telegraph, the team of scientists at the company’s bases in the UK and America are up to "full speed" on testing, and its executives are extremely hopeful of commencing production of an effective treatment next year.
Pascal Soriot, AstraZeneca's chief executive, told The Sunday Telegraph, that the treatment currently under development was "a combination of two antibodies" in a single injection "because by having both you reduce the chance of resistance developing to one antibody". Just like a vaccine sets off a bodily reaction to create its own antibodies, antibody treatment can also be used for a similar purpose. However, since the production of antibody treatment is comparatively more expensive than a vaccine, older and more vulnerable COVID-19 patients "who may not be able to develop a good response to a vaccine" would be given higher priority for the antibody treatment.
Scientists at AstraZeneca are developing a cloned antibody injection that instantly arms the human body to neutralize the coronavirus. This could prove to be a game-changer for COVID-19 patients in the first stages of coronavirus. According to The Sunday Telegraph, the team of scientists at the company’s bases in the UK and America are up to "full speed" on testing, and its executives are extremely hopeful of commencing production of an effective treatment next year.
Pascal Soriot, AstraZeneca's chief executive, told The Sunday Telegraph, that the treatment currently under development was "a combination of two antibodies" in a single injection "because by having both you reduce the chance of resistance developing to one antibody". Just like a vaccine sets off a bodily reaction to create its own antibodies, antibody treatment can also be used for a similar purpose. However, since the production of antibody treatment is comparatively more expensive than a vaccine, older and more vulnerable COVID-19 patients "who may not be able to develop a good response to a vaccine" would be given higher priority for the antibody treatment.
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans